Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring

[1]  J. Y. Kim,et al.  Evaluation of the new Abbott Real-Time EBV assay: fully automated quantification of EBV in whole blood by targeting BLLF1. , 2019, Diagnostic microbiology and infectious disease.

[2]  P. Huynen,et al.  Evaluation of the Abbott RealTime quantitative CMV and EBV assays using the maxCycle protocol in a laboratory automation context. , 2019, Journal of virological methods.

[3]  Richard C. Friedberg,et al.  International Organization for Standardization (ISO) 15189 , 2017, Annals of laboratory medicine.

[4]  V. Vinuesa,et al.  Comparison of the artus Epstein-Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipients. , 2017, Diagnostic microbiology and infectious disease.

[5]  A. Thiébaut,et al.  Dynamics of Epstein‐Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy , 2016, Transplant infectious disease : an official journal of the Transplantation Society.

[6]  A. Heath,et al.  A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques. , 2016, Biologicals : journal of the International Association of Biological Standardization.

[7]  M. Resche-Rigon,et al.  Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system. , 2016, Diagnostic microbiology and infectious disease.

[8]  H. Kessler,et al.  Analytical and clinical performance of a new molecular assay for Epstein-Barr virus DNA quantitation. , 2015, Journal of virological methods.

[9]  A. Pang,et al.  Quantification of circulating Epstein–Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance , 2014, Leukemia.

[10]  B. Gruhn,et al.  Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  J. Seigneurin,et al.  Comparison of Commercial Extraction Systems and PCR Assays for Quantification of Epstein-Barr Virus DNA Load in Whole Blood , 2012, Journal of Clinical Microbiology.

[12]  F. Baldanti,et al.  Multicenter comparative study of Epstein-Barr virus DNA quantification for virological monitoring in transplanted patients. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  M. Gulley,et al.  Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder , 2010, Clinical Microbiology Reviews.

[14]  G. Mazariegos,et al.  Lymphoproliferative Disorders and De Novo Malignancies in Intestinal and Multivisceral Recipients: Improved Outcomes With New Outlooks , 2009, Transplantation.

[15]  J. Fox,et al.  Interlaboratory Comparison of Epstein‐Barr Virus Viral Load Assays , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  F. Gruijl,et al.  Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  B. Gruhn,et al.  Monitoring of Epstein‐Barr virus load after hematopoietic stem cell transplantation for early intervention in post‐transplant lymphoproliferative disease , 2008, Journal of medical virology.

[18]  M. Nikiforova,et al.  Multicenter Comparison of Different Real-Time PCR Assays for Quantitative Detection of Epstein-Barr Virus , 2007, Journal of Clinical Microbiology.

[19]  A. Snow,et al.  Epstein‐Barr Virus: Evasive Maneuvers in the Development of PTLD , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  D. Crawford,et al.  Epstein-Barr virus: the impact of scientific advances on clinical practice. , 2006, Blood.

[21]  M. Callan,et al.  Infectious mononucleosis and Epstein-Barr virus , 2004, Expert Reviews in Molecular Medicine.

[22]  B. van der Holt,et al.  Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. , 2002, Blood.

[23]  J. Preiksaitis,et al.  Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Jaap M Middeldorp,et al.  Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. , 2001, Blood.

[25]  Jaap M Middeldorp,et al.  Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in lung transplant patients. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  O. Caballero,et al.  Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort. , 2004, Haematologica.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  C. E. Rapp,et al.  Infectious mononucleosis and the Epstein-Barr virus. , 1978, American journal of diseases of children.